- In
updated coverage report, SeeThruEquity projects that ETST will hit $2.2
million in sales for FY2019 based on its CBD product distribution and
planned ‘As Seen On TV’ campaign
- Direct
response TV campaign seen raising awareness for ETST, which is eyeing
growth for its line of hemp-derived products, planned pharmaceuticals and medical
device introduction
- A
positive factor cited by the report was ETST’s uplisting to the OTCQB
market; it also sees naming of celebrity Kevin Harrington as its direct
response TV spokesperson as sales catalyst
Earth Science Tech, Inc. (OTCQB: ETST) is estimated by
research firm SeeThruEquity, LLC to reach sales of $2.2 million in FY2019, then
$7.1 million by FY2020, as the company expands its product line and media
visibility in the growing legalized CBD market and fast-growing subcategory of
hemp-based CBD (http://ibn.fm/FkAwY).
ETST has been moving quickly in several areas to position
itself for growth. The company has announced that it is in talks with an
organic CBD grower and processor for it to provide an exclusive business/supply
agreement that will give ETST a consistent industrial hemp source. It has also
announced that it is formulating a full spectrum cannabinoid (CBD) beverage
through its provisional patent via its research with the University of Central
Oklahoma focused on improving immune system functions (http://ibn.fm/D6gcm).
ETST is a biotech company based in Doral, Florida, marketing
and developing CBD products, as well as dietary supplements, for the
pharmaceutical and nutraceutical fields. The company is focused on the
cannabidiol, pharmaceutical and nutraceutical sectors, as well as the
development, through subsidiaries, of medical devices and research. ETST’s goal
is to become a world leader in the CBD space.
Kevin Harrington, a TV celebrity, has been named
spokesperson in the company’s direct response TV ads for its high-grade CBD
oils. The “As Seen On TV” campaign will run for a period of 12 months and will
feature 60-second ETST commercials aired in 10 regions and networks 300 times,
it said (http://ibn.fm/cUrnC).
It is also moving ahead on the development of its Hygee
medical device, finalizing an agreement with Groupe Opmedic Inc. and its
Procrea Fertility Laboratories for lab services to detect sexually transmitted
infections (STIs) in women using Hygee (http://ibn.fm/N0TZp).
On the CBD front, ETST is in discussions with an organic
grower and processor for an exclusive business/supply relationship that offers
the company its outdoor organic industrial hemp plants, mixing, extraction,
bottling and packaging on an exclusive basis (http://ibn.fm/4FzWv).
ETST holds several wholly owned subsidiaries. Cannabis
Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures
and distributes in the recreational sector. Earth Science Foundation, Inc. is
becoming a non-profit and accepts grants and donations to conduct additional
studies. Earth Science Pharmaceutical develops medical diagnostic tools and
vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic
Montreal, Canada-based company that provides ETST with access to government
grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
